TScan Therapeutics

About:

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Website: https://www.tscan.com/

Twitter/X: tscanrx

Top Investors: BlackRock, Google Ventures, Bessemer Venture Partners, RA Capital Management, Longwood Fund

Description:

TScan is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company’s lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. The company is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.